HCPCS code Q5119 — Inj ruxience, 10 mg. Status: Active. Effective Jul 1, 2020. Source: CMS HCPCS Level II.

Q5119

Active

Inj ruxience, 10 mg

Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jul 1, 2020
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9367

MUE — Medically Unlikely Edits

Maximum units of Q5119 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 150
Practitioner Services 150

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00069-0238-01 Ruxience
00069-0249-01 Ruxience

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2020-Q3
    Inj ruxience, 10 mg